Table 3.
Prior to or at baseline | During follow-up | |
---|---|---|
| ||
No treatment | 90 (26%) | 71 (20%) |
Level 1: BT | 182 (52%) | 84 (24%) |
Level 2: PT | 38 (11%) | 79 (23%) |
Level 3: OAB medications | 35 (10%) | 91 (26%) |
Level 4 | 4 (1.2%) | 24 (7%) |
PTNS | 1 (0.3%) | 3 (1%) |
BTX | 2 (0.6%) | 10 (3%) |
SNM | 1 (0.3%) | 11 (3%) |
BT, behavioral therapy; PT, pelvic floor physical therapy; OAB, overactive bladder; PTNS, percutaneous tibial nerve stimulation; BTX, intradetrusor onabotulinumtoxinA; SNM, sacral neuromodulation